{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:37Z","timestamp":1740108157222,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00066-021-01826-w","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T14:03:15Z","timestamp":1628690595000},"page":"946-949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stellenwert der Radiotherapie bei Morbus Hodgkin in intermedi\u00e4ren Stadien","Radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17)"],"prefix":"10.1007","volume":"197","author":[{"given":"Christoph","family":"S\u00fc\u00df","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"K\u00f6lbl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"issue":"16","key":"1826_CR1","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","volume":"35","author":"MPE Andr\u00e9","year":"2017","unstructured":"Andr\u00e9\u00a0MPE, Girinsky\u00a0T, Federico\u00a0M, Reman\u00a0O, Fortpied\u00a0C, Gotti\u00a0M et al (2017) Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial. J\u00a0Clin Oncol 35(16):1786\u20131794. https:\/\/doi.org\/10.1200\/JCO.2016.68.6394","journal-title":"J Clin Oncol"},{"issue":"7","key":"1826_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/annonc\/mdr575","volume":"23","author":"K Behringer","year":"2012","unstructured":"Behringer\u00a0K, Thielen\u00a0I, Mueller\u00a0H, Goergen\u00a0H, Eibl\u00a0AD, Rosenbrock\u00a0J et\u00a0al (2012) Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Ann Oncol 23(7):1093. https:\/\/doi.org\/10.1093\/annonc\/mdr575","journal-title":"Ann Oncol"},{"issue":"10114","key":"1826_CR3","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","volume":"390","author":"P Borchmann","year":"2017","unstructured":"Borchmann\u00a0P, Goergen\u00a0H, Kobe\u00a0C, Lohri\u00a0A et al (2017) PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet 390(10114):2790\u20132802. https:\/\/doi.org\/10.1016\/S0140-6736(17)32134-7","journal-title":"Lancet"},{"issue":"Suppl 4","key":"1826_CR4","doi-asserted-by":"publisher","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","volume":"29","author":"DA Eichenauer","year":"2018","unstructured":"Eichenauer\u00a0DA, Aleman\u00a0BMP, Andr\u00e9\u00a0M, Federico\u00a0M, Hutchings\u00a0M, Illidge\u00a0T et al (2018) Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv19\u2013iv29. https:\/\/doi.org\/10.1093\/annonc\/mdy080","journal-title":"Ann Oncol"},{"key":"1826_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01504-8","author":"AR Filippi","year":"2020","unstructured":"Filippi\u00a0AR, Meregalli\u00a0S, Di Russo\u00a0A, Levis\u00a0M, Ciammella\u00a0P, Buglione\u00a0M et al (2020) Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin\u2019s lymphoma involving the mediastinum. Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-020-01504-8","journal-title":"Radiat Oncol"},{"issue":"4","key":"1826_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00000421-199708000-00006","volume":"20","author":"SS Kulkarni","year":"1997","unstructured":"Kulkarni\u00a0SS, Sastry\u00a0PS, Saikia\u00a0TK, Parikh\u00a0PM, Gopal\u00a0R, Advani\u00a0SH (1997) Gonadal function following ABVD therapy for Hodgkin\u2019s disease. Am J Clin Oncol 20(4):354\u2013357. https:\/\/doi.org\/10.1097\/00000421-199708000-00006","journal-title":"Am J Clin Oncol"},{"key":"1826_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.radonc.2019.05.009","volume":"138","author":"M Levis","year":"2019","unstructured":"Levis\u00a0M, Filippi\u00a0AR, Fiandra\u00a0C, de Luca\u00a0V, Bartoncini\u00a0S, Vella\u00a0D et\u00a0al (2019) Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin\u2019s lymphoma patients. Radiother Oncol 138:52\u201358. https:\/\/doi.org\/10.1016\/j.radonc.2019.05.009","journal-title":"Radiother Oncol"},{"unstructured":"NCCN (2021) NCCN guideline Hodgkin lymphoma. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hodgkins.pdf. Zugegriffen: 5. M\u00e4rz 2021","key":"1826_CR8"},{"issue":"17","key":"1826_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","volume":"372","author":"J Radford","year":"2015","unstructured":"Radford\u00a0J, Illidge\u00a0T, Counsell\u00a0N, Hancock\u00a0B, Pettengell\u00a0R, Johnson\u00a0P et al (2015) Results of a\u00a0trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma. N\u00a0Engl J Med 372(17):1598\u20131607. https:\/\/doi.org\/10.1056\/NEJMoa1408648","journal-title":"N Engl J Med"},{"issue":"10","key":"1826_CR10","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/annonc\/mdn376","volume":"19","author":"M Sieniawski","year":"2008","unstructured":"Sieniawski\u00a0M, Reineke\u00a0T, Josting\u00a0A, Nogova\u00a0L, Behringer\u00a0K, Halbsguth\u00a0T et\u00a0al (2008) Assessment of male fertility in patients with Hodgkin\u2019s lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. Ann Oncol 19(10):1795\u20131801. https:\/\/doi.org\/10.1093\/annonc\/mdn376","journal-title":"Ann Oncol"},{"unstructured":"Skoetz N, Engert A, Eich HT, Schmidberger H et al (2020) S3-Leitlinie Hodgkin Lymphom. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/hodgkin-lymphom\/. Zugegriffen: 5. M\u00e4rz 2021","key":"1826_CR11"},{"issue":"9","key":"1826_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1200\/JCO.2011.38.5807","volume":"30","author":"B von Tresckow","year":"2012","unstructured":"von Tresckow\u00a0B, Pl\u00fctschow\u00a0A, Fuchs\u00a0M, Klimm\u00a0B, Markova\u00a0J, Lohri\u00a0A et al (2012) Dose-intensification in early unfavorable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin Study Group HD14 trial. J\u00a0Clin Oncol 30(9):907\u2013913. https:\/\/doi.org\/10.1200\/JCO.2011.38.5807","journal-title":"J Clin Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-021-01826-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T06:57:29Z","timestamp":1632725849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-021-01826-w"}},"subtitle":["Ergebnisse der HD17-Studie (GHSG)","A\u00a0multicentre phase\u00a0III trial"],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1007\/s00066-021-01826-w","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"6 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.\u00a0S\u00fc\u00df und O.\u00a0K\u00f6lbl geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}